Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychiatry | 12 | 2023 | 118 | 3.360 |
Why?
|
| Neuropsychiatry | 7 | 2024 | 9 | 2.770 |
Why?
|
| Neurosciences | 4 | 2023 | 27 | 1.820 |
Why?
|
| Neurology | 5 | 2024 | 40 | 1.640 |
Why?
|
| Internship and Residency | 10 | 2023 | 787 | 1.630 |
Why?
|
| Amnesia, Anterograde | 1 | 2022 | 3 | 0.810 |
Why?
|
| Neurologic Examination | 3 | 2018 | 52 | 0.770 |
Why?
|
| Brain Injuries | 1 | 2022 | 140 | 0.700 |
Why?
|
| Mental Disorders | 6 | 2016 | 756 | 0.690 |
Why?
|
| Frontal Lobe | 3 | 2022 | 65 | 0.650 |
Why?
|
| Catatonia | 1 | 2016 | 5 | 0.530 |
Why?
|
| Curriculum | 4 | 2021 | 585 | 0.520 |
Why?
|
| Education, Medical | 2 | 2015 | 182 | 0.470 |
Why?
|
| Physicians | 3 | 2015 | 464 | 0.460 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2016 | 120 | 0.460 |
Why?
|
| Clinical Competence | 3 | 2016 | 713 | 0.440 |
Why?
|
| Brain Diseases | 1 | 2015 | 75 | 0.440 |
Why?
|
| Brain | 2 | 2022 | 1550 | 0.430 |
Why?
|
| Antipsychotic Agents | 4 | 2007 | 302 | 0.400 |
Why?
|
| Humans | 28 | 2024 | 62682 | 0.320 |
Why?
|
| Functional Laterality | 1 | 2008 | 138 | 0.290 |
Why?
|
| Dystonia | 1 | 2007 | 13 | 0.280 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 65 | 0.270 |
Why?
|
| Psychotic Disorders | 1 | 2008 | 160 | 0.250 |
Why?
|
| Dementia | 1 | 2008 | 258 | 0.230 |
Why?
|
| Dyskinesia, Drug-Induced | 2 | 1994 | 10 | 0.190 |
Why?
|
| Seizures | 1 | 2022 | 144 | 0.180 |
Why?
|
| Depression | 1 | 2008 | 883 | 0.180 |
Why?
|
| United States | 6 | 2023 | 7721 | 0.180 |
Why?
|
| Psychiatric Rehabilitation | 1 | 2020 | 14 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2020 | 30 | 0.170 |
Why?
|
| Schizophrenia | 3 | 2020 | 267 | 0.170 |
Why?
|
| Arteriovenous Malformations | 1 | 2000 | 43 | 0.160 |
Why?
|
| Psychotherapy | 1 | 2020 | 96 | 0.160 |
Why?
|
| Psychotropic Drugs | 1 | 2020 | 81 | 0.160 |
Why?
|
| Intellectual Disability | 2 | 2008 | 167 | 0.160 |
Why?
|
| Education, Medical, Graduate | 3 | 2016 | 341 | 0.150 |
Why?
|
| History, 19th Century | 1 | 2018 | 44 | 0.150 |
Why?
|
| Psychological Tests | 1 | 2018 | 45 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2018 | 168 | 0.140 |
Why?
|
| Middle Aged | 4 | 2022 | 17365 | 0.140 |
Why?
|
| Bipolar Disorder | 1 | 2000 | 246 | 0.140 |
Why?
|
| Psychopharmacology | 2 | 2009 | 13 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2018 | 229 | 0.140 |
Why?
|
| Child | 3 | 2016 | 4444 | 0.140 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 1996 | 19 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2016 | 42 | 0.130 |
Why?
|
| Psychosurgery | 1 | 1996 | 3 | 0.130 |
Why?
|
| Arachnoid Cysts | 1 | 1996 | 5 | 0.130 |
Why?
|
| Ethnopsychology | 1 | 2016 | 3 | 0.130 |
Why?
|
| Pseudotumor Cerebri | 1 | 1996 | 10 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 1996 | 46 | 0.130 |
Why?
|
| Cultural Competency | 1 | 2016 | 49 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 104 | 0.120 |
Why?
|
| Male | 7 | 2022 | 29487 | 0.120 |
Why?
|
| Adult | 7 | 2018 | 16629 | 0.120 |
Why?
|
| Teaching | 2 | 2014 | 156 | 0.120 |
Why?
|
| Self-Injurious Behavior | 1 | 1995 | 47 | 0.110 |
Why?
|
| Community Mental Health Centers | 1 | 1994 | 18 | 0.110 |
Why?
|
| Naltrexone | 1 | 1995 | 89 | 0.110 |
Why?
|
| Adolescent Psychiatry | 1 | 2014 | 18 | 0.110 |
Why?
|
| Accreditation | 1 | 2014 | 76 | 0.110 |
Why?
|
| Attitude | 1 | 2014 | 100 | 0.110 |
Why?
|
| Child Psychiatry | 1 | 2014 | 40 | 0.100 |
Why?
|
| Informed Consent | 1 | 1994 | 139 | 0.100 |
Why?
|
| Autistic Disorder | 1 | 1995 | 149 | 0.100 |
Why?
|
| Adolescent | 2 | 2016 | 6172 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2014 | 198 | 0.090 |
Why?
|
| Problem-Based Learning | 2 | 2009 | 36 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 587 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2008 | 2150 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 1996 | 1284 | 0.080 |
Why?
|
| Video Recording | 1 | 2009 | 133 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 79 | 0.080 |
Why?
|
| Program Development | 1 | 2009 | 205 | 0.070 |
Why?
|
| Mass Screening | 1 | 1994 | 686 | 0.070 |
Why?
|
| Age of Onset | 1 | 2008 | 175 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 137 | 0.070 |
Why?
|
| Capital Financing | 1 | 2006 | 5 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2014 | 2648 | 0.070 |
Why?
|
| Informatics | 1 | 2006 | 10 | 0.070 |
Why?
|
| Educational Technology | 1 | 2006 | 9 | 0.070 |
Why?
|
| Faculty | 1 | 2006 | 53 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2006 | 79 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 964 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2006 | 112 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 463 | 0.060 |
Why?
|
| Internet | 1 | 2009 | 463 | 0.060 |
Why?
|
| Female | 4 | 2018 | 32495 | 0.060 |
Why?
|
| Students, Medical | 1 | 2006 | 255 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2020 | 393 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 83 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 5403 | 0.040 |
Why?
|
| Young Adult | 1 | 2008 | 4633 | 0.030 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1996 | 31 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2016 | 74 | 0.030 |
Why?
|
| Perphenazine | 1 | 1995 | 5 | 0.030 |
Why?
|
| Dextroamphetamine | 1 | 1995 | 3 | 0.030 |
Why?
|
| Diphenhydramine | 1 | 1995 | 9 | 0.030 |
Why?
|
| Fluoxetine | 1 | 1995 | 44 | 0.030 |
Why?
|
| Movement Disorders | 1 | 1995 | 23 | 0.030 |
Why?
|
| Patient Simulation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Education, Medical, Continuing | 2 | 2006 | 96 | 0.030 |
Why?
|
| Reoperation | 1 | 1996 | 290 | 0.030 |
Why?
|
| Behavioral Medicine | 1 | 1995 | 37 | 0.030 |
Why?
|
| Liability, Legal | 1 | 1994 | 18 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 299 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1995 | 122 | 0.030 |
Why?
|
| Neurocognitive Disorders | 1 | 1993 | 6 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 1995 | 104 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 862 | 0.030 |
Why?
|
| Epilepsy | 1 | 1993 | 110 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2016 | 277 | 0.020 |
Why?
|
| Health Policy | 1 | 1994 | 187 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1994 | 337 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1994 | 989 | 0.020 |
Why?
|
| Incidence | 1 | 1994 | 1367 | 0.020 |
Why?
|
| California | 1 | 2009 | 174 | 0.020 |
Why?
|
| Education | 1 | 2009 | 69 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 1589 | 0.020 |
Why?
|
| Massachusetts | 1 | 1994 | 2061 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 317 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 562 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 485 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1994 | 2540 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 748 | 0.020 |
Why?
|
| Technology | 1 | 2005 | 52 | 0.010 |
Why?
|
| Publishing | 1 | 2005 | 92 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1995 | 46 | 0.010 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 1993 | 1 | 0.010 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 1993 | 3 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1993 | 68 | 0.010 |
Why?
|
| Data Collection | 1 | 1995 | 384 | 0.010 |
Why?
|